Key points are not available for this paper at this time.
Mark A. Sussman et al . (11) report that the immunosuppressants cyclosporin (CsA) and FK506 prevent the development of hypertrophy in transgenic mouse models of intrinsic cardiomyopathy and, of more general import, in a rat model of extrinsic pressure-overload hypertrophy caused by banding of
Müller et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: